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1. Introduction 
Objective To investigate various kinds of causes and consequences for misdiagnosis and 
mistreatment of osteosarcoma (OS). Methods The data from 94 patients with osteosarcoma 
undergoing misdiagnosis and mistreatment were collected and their clinical causes and 
consequences were analyzed retrospectively. Results The causes contributing to the 
misdiagnosis among 94 patients, including that patients delayed to consult physician (36 
cases, 38.3%), patients underwent medical misdiagnosis (34 cases, 36.17%) and both of 
components occurred simultaneously (24 cases, 25.53%). The average duration of 
misdiagnosis was 72.15 d, 7.34 d and 100.68 d, respectively. 28 cases (29.79%) accepted 
traditional Chinese medicine therapy, 22 (23.40%) cases were treated by incorrect 
operation. Perhaps there were 56 patients (59.57%) losting limb-salvage procedure 
opportunity, 16 patients (17.02%) had recurrence after limb-salvage operation, 40 patients 
(42.55%) underwent metastasis induced by misdiagnosis and mistreatment. Conclusion 
the main cause of misdiagnosis and mistreatment of OS is that doctors, patients and their 
parents have deficient professional knowledge of OS. CT and MRI examinations are the 
effective to prevent the misdiagnosis of early OS. The probability of all kinds of diagnoses 
should be estimated sufficient, the therapeutic protocol should be made consummately 
and any other treatment procedures should not be taken blindly for atypical cases before 
question or biopsy. 
Osteosarcoma is the most common bone cancer occurred by teenage, and its onset is more 
occult, higher malignant, and rapid progress, and even early stage lung metastases may 
occur. In recent years, the integrated treatment including chemotherapy, limb-salvage and 
technology-based reconstruction is developed rapidly, which is not only improving the 
survival of patients, but also the quality of life. However its efficacy, quality of life and 
survival mainly depend on the treatment of clinical stage. But it is found practically that 
various kinds of causes and consequences for misdiagnosis and mistreatment of 
osteosarcoma, which lead some patients to amputate and even metastasis of lung and other 
organ. Therefore, here are the analysis and treatment strategies for the 94 patients with 
osteosarcoma undergoing misdiagnosis and mistreatment. 
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2. Materials and methods 
2.1 Case choice   
The data from 94 patients with pathological diagnosis, osteosarcoma undergoing 
misdiagnosis and mistreatment from department of Medical Oncology, Sixth People’s 
Hospital of Shanghai Jiaotong University from Janrary, 2002 to December, 2004 were 
collected and their clinical causes and consequences were analyzed retrospectively. Among 
these 94 patients, the youngest is 5 years old, the eldest is 54 years old and the average is 
21.48 years old; male is 62 cases and female is 32 cases; primary lesions in the distal femur is 
40 cases ( 42.6%), proximal tibia is 28 cases (29.8%), proximal humerus is 10 cases (10.6%), 
proximal femur is 6 cases (6.4%) and distal humerus, distal ulna, calcaneus, iliac crest and 
maxilla is 2 cases respectively, 10 cases totally; according to Enneking & Wolf (1996), stage 
IIB below is 20 cases (21.3%), stage IIB is 36 cases (38.3%), stage IIB above is 18 cases (19.1) 
and unknown stage is 20 cases (21.3%). 
2.2 Measure of remedial treatment 
Most patients had received confirmation of Pathology again in our hospital and meantime 
accepted MRI for localized lesions, CT for chest, bone scan for whole body, B-mode 
ultrasound for abdominal and pelvic and serum LDH and AKP check. Chemotherapy before 
operation was 56 cases, who accepted HD-MTX-CFR,IFO,E-ADM,DDP intravenous 
chemotherapy 3 times and limb-salvage patients should add E-ADM+DDP intravenous 
chemotherapy. Chemotherapy after operation was 92 cases (2 case has given up 
chemotherapy). Among these 90 cases, there were 88 patients operated in our hospital, 
including 34 cases limb-salvage (40.5%) with 20 cases allograft (23.8%), 4 cases autologous 
bone graft (4.8%) and 10 cases artificial joint replacement(11.9%), 54 cases amputation 
(61.1.%) in our hospital and 2 case amputation outside. 
3. Result  
3.1 Causes of misdiagnosis  
Table 1 shows the causes of misdiagnosis for these 94 cases. The factor contribute to 
misdiagnosis of patients was mainly due to the mild and not typical character of the early 
clinical symptoms of osteosarcoma. Patients delayed to consult physician because of the  
 
Reasons of misdiagnosis Cases Male Female 
Patients 
   Motion injury 
   Individual delay 
36(28.30) 
 16(17.02) 
 20(21.28) 
26(27.66) 
 12(12.77) 
 14(14.89) 
10(10.64) 
 4(4.25) 
 6(6.39) 
Doctors 
   Individual delay 
   Misdiagnosis by X-ray 
   Misdiagnosis by 
   pathology 
34(36.17) 
 18(19.15) 
 12(12.77) 
 4(4.25) 
24(25.53) 
 12(12.77) 
 10(10.64) 
 2(2.13) 
10(10.64) 
 6(6.38) 
 10(2.13) 
 2(2.13) 
Both 24(25.53)  12(12.77) 12(12.77) 
Table 1. The analysis of the reasons of misdiagnosis in 47 cases of osteosarcoma [n(%)] 
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intense of study and work which is 21.28%, and the other reason is about 12.77% because of 
the misunderstanding of the motion injuries particularly men’s. The factor contribute to 
patients underwent medical misdiagnosis is 36.17% including the misdiagnosis of motion 
injuries or arthritis particularly men’s. The factor contribute to the physicians’ delay is 
19.15% including the delay of the X-ray examination for patients in time. The misdiagnosis 
of the X-ray examination is 12.77% for the X-ray examination is lack of the typical X-ray for 
osteosarcoma at the same time CT and MRI examination haven’t been taken. Among these 
47 patients, the misdiagnosis contribute to both patients and physicians is 24 cases (25.53%) 
and the average misdiagnosis time reached to 100.68 d, and significantly higher than the 
patients or physician individually. 
3.2 Consequent analysis and mistreatment  
Table 2 analyzed amputation, local recurrence and distant metastasis contribute to 
misdiagnosis and mistreatment. Among these 94 patients, the ratio of amputation was 56 
cases (59.57%) including 44 local amputated cases at a late stage of disease; the ratio of 
distant metastasis was 40 cases (42.55%) including 30 distant metastasis cases before 
treatment and 10 cases after operation, and 8 cases reached CR after chemotherapy; the 
ration of recurrence after operation is 16 cases(17.02% ) including 6 re-amputated cases after 
bone graft and 4 amputated cases because of local recurrence. 28 cases (29.79%) of 
misdiagnosis treated as massage, TCM herbs cupping and other traditional Chinese 
medicine treatment. 22 cases (23.40%) took incorrect surgical procedure, and 4 cases 
(14.25%) took intra-articular infection with antibiotic up to 3 weeks. 
 
Consequences of 
misdiagnosis or 
mistreatment 
case 
misdiagnosis 
Mistreatment with 
misdiagnosis 
Factor of 
patient 
Factor of 
doctor 
Bilateral 
factors 
Traditional 
medicine 
therapy 
Incorrect 
surgery 
Others 
Amputation 56(59.57) 24(25.53) 20(21.28) 12(12.76) 18(19.15) 12(12.77) 2(2.13) 
Distant 
metastasis 
40(42.55) 16(17.02) 14(14.89) 10(10.64) 10(10.64) 4(4.25) 2(2.13) 
Recurrence after 
operation 
16(17.02) 8(8.51) 6(6.38) 6(6.38) 0 6(6.38) 0 
Table 2. The analysis of consequences of misdiagnosis or mistreatment in 94 cases of 
osteosarcoma [n (%)] 
4. Discussion 
Osteosarcoma at the early stage has no typical clinical symptom and the most common 
symptom is the local pain, redness and/or mild dysfunction similar to injury. As 
osteosarcoma occurs in younger’s metaphysis with joint particularly in lower limb joints. 
Those male adolescents who like sports and their parents are likely to mistake the 
osteosarcoma as motion injuries. In addition, most of young patients had heavy burdern of 
learning and lack of the medical knowledge of this disease was the main cause of 
misdiagnosis. Our study showed that the misdiagnosis due to the patients is 38.30% 
especially the misdiagnosis of the male adolescents is 27.06%, and the average misdiagnosis 
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time is 72.15 days. Author thought that it was important to enhance the osteosarcoma 
knowledge disseminate, and if the pain and red around joints has occurred for one week 
particular at night whatever with or withour motion and injured history, X-ray should be 
taken timely in the hospital that has the diagnosis conditions for osteosarcoma. If there is 
any doubt, CT or MRI examinations should be taken in time. 
The misdiagnosis due to the doctors is 36.17%, and the average misdiagnosis day is 57.34 d. 
Most of the doctors especially the doctors from primary hospitals should pay more attention 
to the clinical symptom of osteosarcoma. When some patients had the typical clinical 
symptom as treatment, doctors should not be still subjective to misdiagnose as injury or 
other benign tumors without any imaging. Reviewing 12 osteosarcoma patients with X-ray 
as treatment, author found that almost cases were lack of the typical osteosarcoma’s features 
for the most X-ray with only small range of bone destruction or Codman triangle. Daylight 
occurred rarely and another misdiagnosis of x-ray contributed to poor X-ray rates, poor 
light conditions, incorrect camera position and perspective and other technical factors in the 
primary hospital. Analyzing 4 cases of pathological misdiagnosis, the main factor was less 
needle biopsy material or the material from tumor necrosis zone without tumor cells. In 
addition to educate the knowledge of osteosarcoma to all level of physicians, the 
combination among clinic, imaging and pathology should be emphasized. Although X-ray 
clearly shows the size of the tumor lesions and bone destruction and periosteal reaction, it is 
short of sensitivity and only up to 30% of bone destruction can be detected. So X-ray 
examination cannot check osteosarcoma at the early stage. CT and MRI examinations have 
more resolution than X-ray, and they are the prior methods to exam osteosarcoma. They can 
show the tumor size, location and the relationship to normal tissue more clearly. 
Furthermore they provide the most important evidence to osteosarcoma clinical stage, 
surgical approach2,3. Author thought those osteosarcoma suspected in clinic should be 
checked routine lateral X-ray compared with the healthy side. If necessary, an experienced 
physician should be asked to observe the focus repeatedly under the lesion site. The 
suspicious cases should be taken CT or MRI examination and that is the most effective 
method to prevent misdiagnosis. It is worth mentioned that the biopsy-negative patients 
who are diagnosed as osteosarcoma probable by clinic and imaging should not be biopsied 
repeatedly, to avoid artificial compartment open, clinical stage from stage IIA to IIB and 
cutting tumor cells metastasis. Those cases that are difficult to diagnose should be frozen 
biopsy before surgery by experienced physicians. Mistreatment is in the premise of 
misdiagnosis.  
The misdiagnosis and mistreatment of osteosarcoma at the early stage commonly occur in 
China. Misdiagnisis is relative to patients,relatives and doctors and mistreatment is the 
responsibility of the doctors’. Among 94 cases, 28 patients had massage, TCM herbs cupping 
and other traditional Chinese medicine treatments before diagnosing osteosarcoma; 18 
patients should be operated as local tumor has violated the outdoor and soft tissue; 10 
patients had distant metastasis; 22 patients (23.40%) has taken surgery in local as benign 
tumors or injury; 2 patient has the indications for limb salvage of the proximal humerus 
osteosarcoma as stage IIB, who has freed the line shoulder surgery; 4 patients has been 
treated with antibiotics for arthritic. 
Overtreatment is another question. Neoadjuvant chemptherapy increased survival in 
patients without metastasis, however, the patient who benefit from neoadjvant 
www.intechopen.com
 
Misdiagnosis and Mistreatment for Osteosarcoma: Analysis of Cause and Its Strategy 
 
89 
chemotherapy are those had good histopathological response to chemotherapy 1-5. 
Therefore, it’s important to develop an effective method to evaluate tumor response to 
chemotherapy, so that we can choose right patient to surgery and avoid overtreatment. 
Fluorine-18-fluorodeoxyglucose positron emission tomography with computed tomography 
(PET-CT) is now widely used with promising results in the initial diagnosis, staging, and 
detection of recurrence in many kinds of cancer 6. Furthermore, some studies revealed that 
the change of 18F-FDG uptake after chemotherapy is associated with pathological response, 
providing a good option to noninvasively monitor effectiveness of treatment7-18. We meta-
analyzed eleven studies comprising 233 patients. By analyzing two parameters of PET: SUV 
(standardized uptake value) or TBR (tumor to background ratios), we found that the ratio of 
TBR after treatment (TBR2) to TBR before treatment (TBR1) (TBR2/1), the SUV after therapy 
(SUV2) and the ratio of SUV after treatment (SUV2) to SUV before treatment 
(SUV1)(SUV2/1) have relatively good predicting performance(Table 3, Figure 1a,b,c, 
unpublished data). Therefore, if we want to make decision that when the patient should 
undergo surgical treatment after chemotherapy to avoid overtreatment, the PET-CT scan 
might be the choice. 
 
Studies N Positive LR(95% CI) Q Negative LR(95% CI) Q 
TBR2:1 57 4.26(2.01-9.04) 0.2 0.11 (0.03-0.36) 0.63 
SUV2 138 3.56(1.80-7.0) 1.37 0.56(0.39-0.80 5.72 
SUV2:1 233 1.90(1.27-2.85) 15.13 0.47(0.34-0.66) 7.54 
Table 3. Likelihood ratios for the association between PET and histological response to 
chemotherapy (unpublished). 
  
a) 
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b) 
  
c) 
Fig. 1. The summary receiver operating characteristic (SROC) curves for TBR2:1(a), SUV2 (b) 
and SUV2:1(c) on a per-patient basis. Each solid circle represents each study in the meta-
analysis. The size of the circle indicates the study size. The *Q indexes estimate for TBR2:1, 
SUV2 and SUV2:1 were 0.6859, 0.7055 and 0.7030 respectively. AUC: area under the curve; 
SE, standard error. (unpublished). 
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It is analyzed retrospectively that all misdiagnosed patients have the limb-salvage 
instructions by X-ray film before treatment. Lung was the distant metastasis location for 40 
case and almost cases hadn’t taken Chest CT as treatment. Data of our study shows 
mistreatment not only delay the best time of treatment, but also stimulate the growth of 
tumor cell directly and leading to osteosarcoma cells partial or/and distant metastasis. 
Reviewing previous data, it is commonly misdiagnosed malignancy as carcinoid or 
inflammatory disease with Chinese medical treatment or surgical debridement and bone 
graft, and the main reason of misdiagnosis is the lack of clinical knowledge by physicians. 
Our study indicates the diagnosis of osteosarcoma should combine clinic, imaging and 
pathology as practice. For those atypical clinical manifestations or bone destruction of X-ray 
not clearly for early diagnosis, clinical physicians should read X-ray film carefully and even 
enhance the relationship with radiated and pathological doctor. Before treatment or surgery, 
clinical physicians should estimate all kinds of diagnosis and develop comprehensive 
treatment program , and Chinese medicine treatment can be considered after completely 
getting rid of bone cancer. If the diagnosis of ostemsarcoma has been clearly, chest CT 
should be taken to avoid distant metastasis and develop treatment program before surgery. 
In addition, those patients of extremity osteosarcoma that has the indication for limb salvage 
as stage IIA, in the premise of preoperative chemotherapy, direct surgery may affect life 
quality of patients and the long-term survival may not be improved further. 
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